|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 505 KING AVENUE |
Address2 |
|
City | COLUMBUS |
State | OH |
Zip Code | 43201-2693 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 5585-12
|
||||||||
|
6. House ID# 302170000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Paul T. Doucette |
Date | 4/20/2022 2:46:21 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 5376, S.Con.Res. 14, Draft Bills; Build Back Better Act, Senate FY22 Budget Resolution and reconciliation package; Issues related to DOE R&D, lab infrastructure, Issues related to PFAS; Innovation; NSF; Microelectronics.
H.R. 4549, S. 2605; Energy and Water Development Appropriations Bill, 2022; Title III, Department of Energy, all provisions and issues relating to the Department of Energy, and its science, energy, and national security programs.
H.R. 4505, S.3042; Commerce, Justice, Science and Related Agencies Appropriations Bill, 2022National Science Foundation, Research and Related Activities; FBI, provisions related to biodefense lab operations.
H.R. 4432, S3023; Defense Appropriations Bill, 2022Issues and provisions related to Title II - O&M; Title III - Procurement; Title IV - RDT&E, Title VI - Defense Health, and the Military and National Intelligence programs.
HR 4431, S3058; Department of Homeland Security Appropriations Bill, 2022; Science and Technology Directorate, all issues related to laboratory facilities, and research, development, acquisition, and operations; all issues related to BioWatch program, issues related to chemical and biological readiness. TSA Security Equipment maintenance. Countering Weapons of Mass Destruction Office, issues related to biological defense; USCG O&M.
H.R. 4355, S. 2064; MilCon-VA, 2022; VA - Alternative Pain Medication Research; Neurotechnology; BRAC - PFAS remediation.
H.R. 4356, S. 2599; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022; Spray Drift, FDA PRV.
S. 3060Labor, HHS Appopriations Bill 2022Issues related to HHS; pandemic preparedness, vaccines; CDC.
TBDEnergy and Water Development Appropriations Bill, 2023Title III, Department of Energy, all provisions and issues relating to the Department of Energy, and its science, energy, and national security programs. Issues related to PFAS and AFFF destruction
TBDCommerce, Justice, Science and Related Agencies Appropriations Bill, 2023National Science Foundation, Research and Related Activities; FBI, provisions related to biodefense lab operations;
TBDDefense Appropriations Bill, 2023Issues and provisions related to Title II - O&M; Title III - Procurement; Title IV - RDT&E, Title VI - Defense Health, and the Military and National Intelligence programs.
TBDDepartment of Homeland Security Appropriations Bill, 2023Science and Technology Directorate, all issues related to laboratory facilities, and research, development, acquisition, and operations; issues related to BioWatch and BD21; issues related to chemical and biological readiness. TSA Secruity Equipmemt maintenance. Countering Weapons of Mass Destruction Office, issues related to biological defense; USCG O&M
Labor, HHS Appopriations Bill 2023Issues related to HHS; pandemic preparedness, vaccines; CDC
.
Issues related to the Administration's Fiscal Year 2023 budget request for the Department of Energy and its science, energy, and national security programs.
Issues related to Vaccine Durability and efficacy; K-12 COVID-19 testing; genomic sequencing; pandemic response.
Issues related to infrastructure spending: PFAS remediation; I-ARPA.
Issues related to DOE audit strategies.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Toler |
|
|
|
Paul |
Doucette |
|
|
|
Jeffrey |
Rose |
|
|
|
Heather |
Hescheles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
TBD; House National Defense Authorization Act for Fiscal Year 2023; Senate National Defense Authorization Act for Fiscal Year 2022; Issues and provisions related to Title II - O&M; Title III - Procurement; Title IV - RDT&E, Title VI - Defense Health, the Military and National Intelligence programs and environmental restoration and PFAS destruction Technology.
Draft Bills, S. 1260; Endless Frontier Act - (117th Congress) the Innovation and Competition Act of 2021; R&D Funding; Innovation; Semiconductor and Microelectronics Investments.
H.R. 4432, S. 3023; Defense Appropriations Bill, 2022 Issues and provisions related to Title II - O&M; Title III - Procurement; Title IV - RDT&E, Title VI - Defense Health, and the Military and National Intelligence programs.
Draft Bills; Defense Appropriations Bill, 2023Issues and provisions related to Title II - O&M; Title III - Procurement; Title IV - RDT&E, Title VI - Defense Health, and the Military and National Intelligence programs.
Issues related to NNSA weapons and nonproliferation programs.
S. 3799PREVENT Pandemics Act; Issues related to Biosecurity; Biopreparedness; Biotechnology; CDMRP - SCIRP, Congressionally Directed Medical Research Program - Spinal Cord Injury Research Program; Neurotechnology.
Semiconductor / Microelectronics Manufacturing and Research.
Issues related to military health and rehabilitation; veteran rehabilitation; neurotechnology
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Doucette |
|
|
|
Jeff |
Rose |
|
|
|
Heather |
Hescheles |
|
|
|
Mary |
Toler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
H.R. 5376; Build Back Better Act; Issues related to DOE R&D and lab infrastructure.
Draft Bill; Hydrogen and Fuel Cell R&D; Issues related to DOE Hydrogen R&D programs.
Issues related to Department of Energy Office of Fossil Energy.
Issues related to Department of Energy technology transfer and commercialization policies.
Issues related to smart grid, energy storage and electricity cybersecurity funding, programs, facilities and initiatives.
Issues related to nuclear infrastructure and advanced reactor technologies.
Issues related to biological and environmental research, and climate programs and laboratories.
Issues related to DOE's renewable energy, energy efficiency, nuclear energy and fossil energy R&D programs.
Issues related to the Administration's Fiscal Year 2023 budget requests for the Department of Energy and its science, energy, and national security programs.
Issues related to national laboratory facilities and infrastructure funding, financing, and operations.
Issues related to R&D in support of cleanup and nuclear security missions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Toler |
|
|
|
Paul |
Doucette |
|
|
|
Jeff |
Rose |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
HR 3593, Draft Senate Bill; DOE Science for the Future Act; All titles and sections.
S. 1260; US Innovation and Competition Act of 2021; All titles and sections.
H.R. 4521; America COMPETES Act of 2022; All titles and sections.
Issues related to the Department of Energy Office of Science funding, programs, facilities, and initiatives.
Issues related to nuclear physics research and facilities and isotope production.
Issues related to Department of Energy technology transfer and commercialization policies.
Issues related to federal funding for basic scientific research and university research grant programs.
Issues related to Department of Energy supercomputing, quantum information sciences and artificial intelligence/machine learning.
Issues related to fusion energy research and international collaborations.
Issues related to national laboratory facilities and infrastructure funding, financing, and operations.
Issues related to nominations for S&T positions.
Issues related to biomanufacturing, biosecurity, and biopreparedness.
Issues related to neurotechnology.
Issues related to NSF; R&D and Innovation investments.
Issues related to Semiconductor / Microelectronic manufacturing and research.
Issues related to research security.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Toler |
|
|
|
Paul |
Doucette |
|
|
|
Heather |
Hescheles |
|
|
|
Jeff |
Rose |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
H.R. 4431, S 3058; Department of Homeland Security Appropriations Bill, 2022; Issues related to DHS Science and Technology Directorate chem-bio defense mission and laboratory operations; TSA TSL and Procurement, Construction and Improvements; Countering Weapons of Mass Destruction Office issues related to R&D and biodefense; Biowatch and BD21 programs.
Draft Bills; Department of Homeland Security Appropriations Bill, 2023Issues related to DHS Science and Technology Directorate chem-bio defense mission and laboratory operations, research, and infrastructure; TSA TSL and Procurement, Construction and Improvements; Countering Weapons of Mass Destruction Office issues related to R&D and biodefense; Biowatch and BD21 programs
Issues related to CWMD; BD21
Issues related to DHS S&T Directorate.
Issues related to laboratory facilities and infrastructure.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Doucette |
|
|
|
Jeff |
Rose |
|
|
|
Heather |
Hescheles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 3799;Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or the PREVENT Pandemics Act; Issues related to pandemic prevention; testing; surveillance.
S. 3060; Labor, HHS Appopriations Bill 2022; Issues related to HHS; pandemic preparedness, vaccines; CDC.
Draft Bill; Labor, HHS Appropriations Bill 2023; Issues related to HHS; pandemic preparedness, vaccines; CDC.
Issues related to COVID-19 testing and vaccine studies; Vaccine durability and efficacy; genomic sequencing; pandedmic preparedness and response.
Issues related to military health and rehabilitation (neurotechnology).
Issues related to Infrastructure spending; I-ARPA.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeff |
Rose |
|
|
|
Heather |
Hescheles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Issues related to DOD PFAS site assessments, Remediation and destruction technology; AFFF destruction
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeffrey |
Rose |
|
|
|
Heather |
Hescheles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |